OncoNano Medicine

0 followers


OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeut... Read more

Industries

Headquarters

Employees

Links

Org chart

Kartik Krishnan
Chief Executive Officer
Don Kruppa
VP, Technical Operations
Kathy Rath
VP, Regulatory Affairs
Ruolan Han
Vice President, Nonclinical And Translational Research
Tian Zhao
Vice President, R&d